Comprehensive Spine and Pain Management, LLC
Comprehensive Spine and Pain Management, LLC was paid $323K by Medicaid between Jan 2018 and Apr 2022, across 13 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 49% of everything it billed.
33Billing provider infoCOMPREHENSIVE SPINE AND PAIN MANAGEMENT, LLC
NEWARK, DE 19713
NEWARK, DE 19713
33aNPI1508298134assigned 08/06/2013
33bProvider typeSpecialist
28Total paid$323K
24GClaims10,510
24DCodes billed13
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Specialist providers in Delaware
Rank by total paid#10 of 27
Median peer was paid$103K
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,137 | $19K | |
| 2019 | 3,139 | $55K | |
| 2020 | 1,981 | $153K | |
| 2021 | 1,093 | $83K | |
| 2022 | 160 | $13K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 49% | 4,384 | 2,539 | $159K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 1,898 | 1,392 | $116K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.2% | 279 | 232 | $17K |
| 76942 | 5.2% | 1,319 | 895 | $17K | |
| 20553 | 2.4% | 1,292 | 867 | $8K | |
| 64635 | <1% | 42 | 39 | $3K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 644 | 585 | $2K |
| 64636 | <1% | 42 | 39 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 334 | 276 | $755.74 |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 15 | 13 | $129.52 |
| 80305 | <1% | 95 | 85 | $11.97 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 83 | 73 | $10.98 |
1 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 83 | $5.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPATEL, ASIT (OWNER)